Brief: Boiron Signs Agreement With Panaxia Malta For Research And Development Of Cannabis For Medical Use

Boiron SA

24/02/2026 14:56

Feb 24 (Reuters) - Boiron SA BOIR.PA:

SIGNING OF AN AGREEMENT WITH PANAXIA MALTA, A COMPANY SPECIALISING IN RESEARCH AND DEVELOPMENT OF CANNABIS FOR MEDICAL USE

THIS PARTNERSHIP CONSISTS OF AN OPTION, EXERCISABLE FROM 2029, FOR BOIRON TO ACQUIRE A MAJORITY STAKE IN PANAXIA MALTA

THIS OPTION, GRANTED IN EXCHANGE FOR A PAYMENT OF UP TO EUR 3.2 MILLION, SHOULD ENABLE PANAXIA TO CONTINUE ITS DEVELOPMENT IN EUROPEAN COUNTRIES WHERE CANNABIS FOR MEDICAL USE IS AUTHORISED

AS PART OF FRANCE'S TESTING OF MEDICAL CANNABIS IN THE COUNTRY, BOIRON HANDLED THE DISTRIBUTION OF PANAXIA MEDICINES

Source text: ID: nACT96715

Further company coverage: BOIR.PA

(Gdansk Newsroom)

((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00; ))